Skip to main content

ESTUDIO DEL PAPEL ANTI-INFLAMATORIO DE LA APOLIPOPROTEINA E (APOE) EN AUTOINMUNIDAD

SAF2012-34059

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Nacional de Proyectos de Investigación Fundamental
Subprogram Subprograma de Proyectos de Investigación Fundamental no Orientada
Call Proyectos I+D
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Investigación, Desarrollo e Innovación
Beneficiary centre UNIVERSIDAD DE CANTABRIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol

  • Alvarez, Pilar
  • Genre, Fernanda|||0000-0003-3612-1448
  • Iglesias, Marcos
  • Augustín Rodríguez, Juan Jesús
  • Tamayo, Esther
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Lavín Gómez, Bernardo|||0000-0001-7279-7643
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Merino Pérez, Ramón|||0000-0002-5306-0635
  • Merino Pérez, Jesús|||0000-0003-3476-1150
Apolipoprotein E (ApoE) deficiency promoted an exacerbation of autoimmune arthritis in mice by inducing proinflammatory immune responses. In this study we analysed the contribution of hypercholesterolaemia and/or the absence of ApoE anti-inflammatory properties, unrelated to its function in the control of cholesterol metabolism, towards the acceleration of arthritis in these mutant animals. The induction and severity of collagen type II-induced arthritis (CIA) were compared for B10.RIII wild-type (WT), B10.RIII.ApoE, B10.RIII.ApoE and B10.RIII.low-density lipoprotein receptor (LDLR) mice with different concentrations of circulating ApoE and cholesterol. A 50-70% reduction in serum levels of ApoE was observed in heterozygous B10.RIII.ApoE mice in comparison to B10.RIII.WT, although both strains of mice exhibited similar circulating lipid profiles. This ApoE reduction was associated with an increased CIA severity that remained lower than in homozygous B10.RIII.ApoE mice. An important rise in circulating ApoE concentration was observed in hypercholesterolaemic B10.RIII.LDLR mice fed with a normal chow diet, and both parameters increased further with an atherogenic hypercholesterolaemic diet. However, the severity of CIA in B10.RIII.LDLR mice was similar to that of B10.RIII.WT controls. In conclusion, by comparing the evolution of CIA between several strains of mutant mice with different levels of serum ApoE and cholesterol, our results demonstrate that both hypercholesterolaemia and ApoE regulate the intensity of in-vivo systemic autoimmune responses.